Alternative lending giant Goldman Sachs Asset Management is looking to raise as much as $3 billion for a new climate credit ...
Metsera, Inc. (Nasdaq: MTSR) ("Metsera"), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone ...
Geneos Wealth Management Inc. purchased a new stake in shares of Diamondback Energy, Inc. (NASDAQ:FANG – Free Report) in the ...
Atlas Energy Solutions Inc. (NYSE: AESI) (“Atlas” or the “Company”) today announced the pricing of an upsized underwritten public offering (the “Offer ...
Alexandria Real estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE ) today announced that it has priced a public offering of $550,000,000 aggregate principal amount of 5.50% senior notes ...
NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: MTSR) (“Metsera”), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone (NuSH) analog ...
In a report released today, Kate McShane from Goldman Sachs maintained a Hold rating on Williams-Sonoma (WSM – Research Report), with a price ...
Smithfield will not receive any proceeds from the sale of the shares by the selling shareholder. Acting joint lead ...
Goldman Sachs downgraded the vaccine maker to Neutral from Buy and slashed its stock-price target to $51 from $99 Wednesday.
Goldman Sachs staffers are unhappy with their scanty bonuses, especially when compared to the 26% surge in CEO David ...
SAN FRANCISCO, Jan. 28, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative ...